Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Alla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|November 18, 2010
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 functionBrigitte M Pützer, Marc Steder, Vijay Alla
Cancer Research|November 12, 2015
p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p ControlClaudia Meier, Philip Hardtstock, Sophie Joost, et al.
The Journal of Biological Chemistry|October 9, 2008
Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1Tomás Racek, Sven Buhlmann, Franziska Rüst, et al.
Oncotarget|July 30, 2014
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirusHolger Schipper, Vijay Alla, Claudia Meier, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Cancer Letters|May 20, 2008
Human leukocyte elastase counteracts matrix metalloproteinase-7 induced apoptosis resistance of tumor cellsVijay Alla, Anubha Kashyap, Sebastian Gregor, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia MutationsOliver Brabetz, Vijay Alla, Linus Angenendt, et al.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
The Journal of Pathology|July 22, 2014
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectinClaudia Meier, Alf Spitschak, Kerstin Abshagen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|November 18, 2010
Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 functionBrigitte M Pützer, Marc Steder, Vijay Alla
Cancer Research|November 12, 2015
p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p ControlClaudia Meier, Philip Hardtstock, Sophie Joost, et al.
The Journal of Biological Chemistry|October 9, 2008
Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1Tomás Racek, Sven Buhlmann, Franziska Rüst, et al.
Oncotarget|July 30, 2014
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirusHolger Schipper, Vijay Alla, Claudia Meier, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2012
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryVijay Alla, Bhavani S Kowtharapu, David Engelmann, et al.
Cancer Letters|May 20, 2008
Human leukocyte elastase counteracts matrix metalloproteinase-7 induced apoptosis resistance of tumor cellsVijay Alla, Anubha Kashyap, Sebastian Gregor, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia MutationsOliver Brabetz, Vijay Alla, Linus Angenendt, et al.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
The Journal of Pathology|July 22, 2014
Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectinClaudia Meier, Alf Spitschak, Kerstin Abshagen, et al.
Pageof 2